Intensity Therapeutics, Inc. Common stock (INTS) Live Share Price, Invest From India

Intensity Therapeutics, Inc. Common stock Stock Performance

as on April 18, 2026 at 6:56 am IST

Day's Low
Day's High
$5.20
Day's Price Range
$5.42
$5.33
2.44%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
$4.63
52-Week Price Range
$48.56
$5.33
13.09%
Downside
811.07%
Upside

Intensity Therapeutics, Inc. Common stock share price movements today

Previous Close: $5.32
Open: $5.22
Volume: 392.8K
Day's Low - High: $5.20 - $5.42
52 Week Low - High: $4.63 - $48.56

Intensity Therapeutics, Inc. Common stock Historical Returns

1 Month Return: -18.03 %
3 Month Return: -47.88 %
1 Year Return: -88.5 %
3 Year Return: 0 %
5 Year Return: 0 %

Intensity Therapeutics, Inc. Common stock Stock Fundamentals & Key Indicators

Check Intensity Therapeutics, Inc. Common stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.5M

EPS (TTM)

-3.6033

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-156.90%

Intensity Therapeutics, Inc. Common stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Intensity Therapeutics, Inc. Common stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Intensity Therapeutics, Inc. Common stock	BUY	$13.5M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	130.51%	136.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$110.8B	98.57%	28.42	32.94%
BeiGene, Ltd.	NA	$36.8B	NA	129.84	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	48.43%	17.98	31.41%

Stock Returns calculator for Intensity Therapeutics, Inc. Common stock Stock including INR - Dollar returns

The Intensity Therapeutics, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Intensity Therapeutics, Inc. Common stock investment value today

Current value as on today

₹12,520

Returns

-₹87,480

(-87.48%)

Returns from Intensity Therapeutics, Inc. Common stock Stock

-₹88,476 (-88.48%)

Dollar Impact

₹996 (+1.00%)

Analyst Recommendation on Intensity Therapeutics, Inc. Common stock Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Intensity Therapeutics, Inc. Common stock. Average target price of $41.5

Intensity Therapeutics, Inc. Common stock Share Price Target

Get share price movements and forecasts by analysts on Intensity Therapeutics, Inc. Common stock.

What analysts predicted

87.16%UPSIDE

Target Price

$41.5

Current Price

$5.33

Analyzed by

7 Analysts

Target

$41.50

Intensity Therapeutics, Inc. Common stock target price $41.5, a slight upside of 87.16% compared to current price of $5.33. According to 7 analysts rating.

Intensity Therapeutics, Inc. Common stock Stock’s Investor Sentiment and Interest

Search interest for Intensity Therapeutics, Inc. Common stock Stock has decreased by -93% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 19, 2026 to April 18, 2026

Change:-93% versus previous 30 day period

Intensity Therapeutics, Inc. Common stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-3	-4	-5	-3	-3	-3	-2	-2	-3
EBITDA	-2	-3	-4	-5	-3	-3	-3	-2	0	-3
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-3	-4	-4	-3	-3	-3	-2	-2	-3
Income Tax Expense	0	0	0	-	-	0	-	-	-	-
Net Income	-2	-3	-4	-4	-3	-3	-3	-2	-2	-3
Net Profit Margin	0.00%	-1123.69%	0.00%	0.00%	0.00%	-13254.17%	0.00%	0.00%	0.00%	11734.62%

Intensity Therapeutics, Inc. Common stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0	0
Operating Income	-5	-6	-8	-7	-8	-16	-11
EBITDA	-5	-6	-8	-7	-10	-16	-11
Interest Expense	-	-	0	0	0	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-5	-6	-7	-7	-10	-16	-11
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-5	-5	-7	-7	-10	-16	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Intensity Therapeutics, Inc. Common stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-4	-4	-3	-3	-3	-2	-2	-3
Operating Cash Flow	0	-4	-4	-3	-2	-1	-2	-2	-2
Investing Cash Flow	2	3	0	3	-9	-	-	-	-
Financing Cash Flow	0	0	0	0	2	0	3	7	7
Change in Cash	1	-1	-4	0	0	-1	1	4	4

Intensity Therapeutics, Inc. Common stock Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-7	-7	-10	-16	-11
Operating Cash Flow	-5	-6	-5	-7	-15	-9
Investing Cash Flow	4	-	-	-6	6	-
Financing Cash Flow	6	2	2	20	2	18
Change in Cash	5	-4	-3	7	-5	9

Global Institutional Holdings in Intensity Therapeutics, Inc. Common stock

Funds	Holdings
Goss Wealth Management LLC	0.04%
Jane Street Group LLC	0.1%
Tower Research Capital LLC	0.03%
Geode Capital Management, LLC	0.72%
Stonebridge Financial Group, LLC	0.12%

See all

Insights on Intensity Therapeutics, Inc. Common stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 127.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, INTS stock has moved down by -3.3%

About Intensity Therapeutics, Inc. Common stock

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Organisation	Intensity Therapeutics, Inc. Common stock
Headquarters	1 Enterprise Drive, Shelton, CT, United States, 06484-4779
Industry	Biotechnology
CEO	Mr. Lewis H. Bender M.A., M.B.A., M.S.
E-voting on shares	Click here to vote

Key Management of Intensity Therapeutics, Inc. Common stock

Name	Title
Mr. Lewis H. Bender M.A., M.B.A., M.S.	Founder, President, CEO & Chairman of the Board
Mr. Joseph Talamo CPA, M.B.A.	Chief Financial Officer
Mr. John Wesolowski CPA, M.B.A.	Principal Accounting Officer & Controller
Mr. James M. Ahlers	Executive Vice President of Corporate Finance

FAQs

What is Intensity Therapeutics, Inc. Common stock share price today?

Intensity Therapeutics, Inc. Common stock share price today is $5.33 as on April 18, 2026 at 1:26 am IST at the close of the market. Intensity Therapeutics, Inc. Common stock share today touched a day high of $5.42 and a low of $5.2.

What is the 52 week high and 52 week low for Intensity Therapeutics, Inc. Common stock share?

Intensity Therapeutics, Inc. Common stock share touched a 52 week high of $48.56 on April 21, 2025 and a 52 week low of $4.63 on August 1, 2025. Intensity Therapeutics, Inc. Common stock stock price today i.e. April 18, 2026 at 1:26 am IST is closed at $5.33,which is 89.02% down from its 52 week high and 15.06% up from its 52 week low.

What is Intensity Therapeutics, Inc. Common stock's market capitalisation today?

Intensity Therapeutics, Inc. Common stock market capitalisation is $0.00T as on April 18, 2026 at 1:26 am IST.

How to invest in Intensity Therapeutics, Inc. Common stock Stock (INTS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Intensity Therapeutics, Inc. Common stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intensity Therapeutics, Inc. Common stock Shares that will get you 0.2814 shares as per Intensity Therapeutics, Inc. Common stock share price of $5.33 per share as on April 18, 2026 at 1:26 am IST.

What is the minimum amount required to buy Intensity Therapeutics, Inc. Common stock Stock (INTS) from India?

Indian investors can start investing in Intensity Therapeutics, Inc. Common stock (INTS) shares with as little as ₹92.768 or $1 (as of April 18, 2026 at 4:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Intensity Therapeutics, Inc. Common stock stock (as per the Rupee-Dollar exchange rate as on April 18, 2026 at 4:40 am IST). Based on Intensity Therapeutics, Inc. Common stock share’s latest price of $5.33 as on April 18, 2026 at 1:26 am IST, you will get 1.8762 shares of Intensity Therapeutics, Inc. Common stock. Learn more about fractional shares .